Game-changing gene therapies present cost problems for health execs – ModernMedicine
ModernMedicine |
Game-changing gene therapies present cost problems for health execs
ModernMedicine The recent approval of two cell-based gene therapies has healthcare executives scratching their heads about ways to manage these anticipated costly drugs, say experts. In August, the FDA approved Novartis’s tisagenlecleucel (Kymriah), the first … |
|
Cancer Immunotherapy? There’s a Synthetic Gene Circuit for That
Genetic Engineering & Biotechnology News The scientists say that their synthetic biology approach, which has been shown to work in an in vivo model of ovarian cancer, can be tweaked to recognize other cancers. By treating the genomes of different kinds of cells as though they were application … |
|
Cancer Immunotherapy? There’s a Synthetic Gene Circuit for That
Genetic Engineering & Biotechnology News The scientists say that their synthetic biology approach, which has been shown to work in an in vivo model of ovarian cancer, can be tweaked to recognize other cancers. By treating the genomes of different kinds of cells as though they were application … |
Parkinson’s News Today |
MIT Researchers Use Genome Editing to Seek Genes that Protect Against Parkinson’s
Parkinson’s News Today Then, they applied the modified version of CRISPR in yeast cells overproducing alpha-synuclein, a protein found in Parkinson’s disease (PD) patients’ brains. In theory, this technique allows scientists to identify genes that protect cells from the PD … |